MINNEAPOLIS, MN, May 29, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA),
an industrial biotechnology company producing sustainable chemicals,
today announced that Ellen Richstone and Henry "Pete" Linsert, Jr. were
elected to BioAmber's board of directors at the Annual Meeting of
Shareholders held on May 27, 2014.
Ray Land, BioAmber's Chairman of the Board, indicated that Pete Linsert
brings to the board unique insight into the financing, scale-up,
operation and expansion of industrial biotechnology, while Ellen
Richstone adds significant finance and corporate governance experience.
Mr. Land added, "Both Ellen and Pete have unique perspectives and
extensive backgrounds with a broad range of companies and solid
business acumen. We look forward to the Company benefitting from their
valuable contributions going forward."
Ms. Richstone and Mr. Linsert were elected by BioAmber's stockholders as
Class I directors, each to hold office until the 2017 annual meeting of
stockholders. Ms. Richstone will serve on the Nominating and Corporate
Governance Committee and the Audit Committee, and was designated by the
Board as an "audit committee financial expert." Mr. Linsert will serve
on the Compensation Committee.
About Ellen Richstone
Ms. Richstone was the Chief Financial Officer of several public and
private companies between 1989 and 2012, including Rohr Aerospace (a
Fortune 500 Company). From 2002 to 2004, Ms. Richstone served as
President and Chief Executive Officer of the Entrepreneurial Resources
Group. From 2004 until its sale in 2007, Ms. Richstone was the
financial expert on the board of directors of American Power
Conversion. Currently, she serves on the corporate advisory boards of
Paxeramed, a medical device company, and Pro Teck Valuation Services,
and on the boards of non-profit organizations Employment Resources Inc.
and the National Association of Corporate Directors-New England. In
April 2013, Ms. Richstone was the recipient of the first annual
Distinguished Director Award from the Corporate Directors Group. Ms.
Richstone graduated from Scripps College in Claremont California and
holds graduate degrees from the Fletcher School of Law and Diplomacy at
Tufts University. She also completed the Advanced Professional
Certificate in Finance at New York University's Graduate School of
Business Administration and attended the Executive Development program
at Cornell University's Business School. Ms. Richstone holds an
Executive Master's Certification in Director Governance from the
American College of Corporate Directors.
About Henry "Pete" Linsert, Jr.
Mr. Linsert was the Chairman of the Board and Chief Executive Officer of
Martek Biosciences Corporation from 1989 to 2006. Mr. Linsert
subsequently founded Columbia Biosciences Corporation, a developer and
manufacturer of fluorescent proteins, antibody conjugates and protein
purification ligands, in 2007. Prior to Martek, Mr. Linsert held
several leadership positions in venture capital and investment firms.
He also served as Captain in the United States Marine Corps. Mr.
Linsert received an M.A. in economics from George Washington University
and a B.A. in economics from Duke University. In 2009, Mr. Linsert was
one of the three inductees in the Space Technology Hall of Fame. Mr.
Linsert currently serves on the review committee of the U.S. National
Academies of Sciences for Technology, Innovation and Entrepreneurship.
BioAmber (NYSE: BIOA) is an industrial biotechnology company producing
sustainable chemicals. Its proprietary technology platform combines
industrial biotechnology and chemical catalysis to convert renewable
feedstock into sustainable chemicals for use in a wide variety of
everyday products including plastics, resins, food additives and
personal care products. For more information visit www.bio-amber.com.
SOURCE: BioAmber Inc.
For further information:
BioAmber Investor Contact
LifeSci Advisors, LLC
1350 Avenue of the Americas, 28th Floor
New York, NY 10019